CRNX · Crinetics Pharmaceuticals, Inc. · Debt
Market Cap
$9.01B
Shares
106.07M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1658247
CUSIP
22663K107
13F (30d)
162 filings
162 filers
Visit website
Investor relations